These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma. Coiffier B; Salles G Blood; 2004 Sep; 104(5):1584-5; author reply 1585-6. PubMed ID: 15317734 [No Abstract] [Full Text] [Related]
48. Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis: treatment and outcome. Bernardeau M; Auroux J; Cavicchi M; Haioun C; Tsakiris L; Delchier JC Pancreatology; 2002; 2(4):427-30. PubMed ID: 12138234 [TBL] [Abstract][Full Text] [Related]
49. Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma. Ennishi D; Yokoyama M; Mishima Y; Watanabe C; Terui Y; Takahashi S; Takeuchi K; Ikeda K; Tanimoto M; Hatake K Leuk Lymphoma; 2007 Nov; 48(11):2241-3. PubMed ID: 17990181 [No Abstract] [Full Text] [Related]
50. Chemotherapy as treatment for colo-colonic intussusception associated with acquired immune deficiency syndrome-related lymphoma. Lerner A; Soto J; Rosen JE Surgery; 2011 May; 149(5):726-7. PubMed ID: 19962169 [No Abstract] [Full Text] [Related]
51. Relapsed diffuse large B-cell lymphoma--10 years later. Jain S; Shah N; Gregory S Clin Adv Hematol Oncol; 2011 Sep; 9(9):704-8. PubMed ID: 22402517 [No Abstract] [Full Text] [Related]
52. Large solitary splenic diffuse large B cell lymphoma in a hepatitis C virus-infected patient. Kedmi M; Fridlander T; Ilan Y; Shibolet O Isr Med Assoc J; 2005 May; 7(5):346-7. PubMed ID: 15909475 [No Abstract] [Full Text] [Related]
54. The rapidly expanding role of rituximab in the treatment of aggressive B-cell lymphoma. Cooper D Cancer J; 2002; 8(5):364-6. PubMed ID: 12416891 [No Abstract] [Full Text] [Related]
55. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147 [TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era. Seo S; Hong JY; Yoon S; Yoo C; Park JH; Lee JB; Park CS; Huh J; Lee Y; Kim KW; Ryu JS; Kim SJ; Kim WS; Yoon DH; Suh C Oncotarget; 2016 Nov; 7(47):76934-76943. PubMed ID: 27764777 [TBL] [Abstract][Full Text] [Related]
57. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. Alliot C J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060 [No Abstract] [Full Text] [Related]